Literature DB >> 26973392

Pathophysiology of chronic pancreatitis induced by dibutyltin dichloride joint ethanol in mice.

Hong Zhang1, Bin Liu1, Xiao-Fan Xu1, Ting-Ting Jiang1, Xiao-Qin Zhang1, Ying-Li Shi1, Yu Chen1, Fang Liu1, Jie Gu1, Lin-Jia Zhu1, Nan Wu1.   

Abstract

AIM: To search for a new chronic pancreatitis model in mice suitable for investigating the pathophysiological processes leading to pancreatic fibrosis.
METHODS: The mice were randomly divided into 2 groups (n = 50), control group and model group. The mice in model group were given ethanol (10%) in drinking water after injection of dibutyltin dichloride (DBTC) (8 mg/kg BW) in tail vein. The mice in control group were injected with only solvent into tail vein (60% ethanol, 20% glycerine and 20% normal saline) and drank common water. At days 1, 7, 14, 28, and 56 after application of DBTC or solvent, 10 mice in one group were killed at each time point respectively. Blood was obtained by inferior vena cava puncture. The activity of amylase, concentration of bilirubin and hyaluronic acid in serum were assayed. The pancreas was taken to observe the pancreatic morphology by HE staining, and to characterize the pancreatic fibrosis by Masson staining. The expression of F4/80, CD3 and fibronectin (FN) were assayed by immuno-histochemistry or Immunofluorescence technique. Collagen type I (COL1A1) in pancreas were detected by Western blot. The expression of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA in the pancreas was assessed by real time PCR.
RESULTS: DBTC induced an acute edematous pancreatitis within 1 d. The dilated acini, scattered acinar cell necrosis, and inflammatory cells were found at day 7. Extensive infiltration with inflammatory cells following deposition of connective tissue was observed at day 14. At day 28, level of pancreatic fibrosis was aggravated. The pancreatic tissue was replaced by an extended interstitial fibrosis at the end of 2 mo. There was significant difference in the level of amylase, bilirubin and hyaluronic acid in serum between control group and model group (P < 0.05). The level of COL1A1 and FN in pancreas increased. The expression of MMP-1 mRNA in pancreas decreased, but TIMP-1 mRNA increased at model group.
CONCLUSION: DBTC joint Ethanol drinking can induce chronic pancreatitis in accordance with the pathophysiological modification of human. DBTC joint Ethanol-induced pancreatitis in mice is an effective and handy experimental method. The model is suitable to study the mechanism of pancreatic fibrosis in chronic pancreatitis.

Entities:  

Keywords:  Animal; Chronic pancreatitis; Dibutyhin dichloride; Ethanol models; Fibrosis; Pathophysiology

Mesh:

Substances:

Year:  2016        PMID: 26973392      PMCID: PMC4779919          DOI: 10.3748/wjg.v22.i10.2960

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride.

Authors:  G Sparmann; J Merkord; A Jäschke; H Nizze; L Jonas; M Löhr; S Liebe; J Emmrich
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

Review 2.  Chronic pancreatitis, a comprehensive review and update. Part I: epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features.

Authors:  Thiruvengadam Muniraj; Harry R Aslanian; James Farrell; Priya A Jamidar
Journal:  Dis Mon       Date:  2014-12       Impact factor: 3.800

3.  Myeloid, but not pancreatic, RelA/p65 is required for fibrosis in a mouse model of chronic pancreatitis.

Authors:  Matthias Treiber; Patrick Neuhöfer; Elisabeth Anetsberger; Henrik Einwächter; Marina Lesina; Mariana Rickmann; Song Liang; Timo Kehl; Hassan Nakhai; Roland M Schmid; Hana Algül
Journal:  Gastroenterology       Date:  2011-07-18       Impact factor: 22.682

4.  Repeated administration of a mild acute toxic dose of di-n-butyltin dichloride at intervals of 3 weeks induces severe lesions in pancreas and liver of rats.

Authors:  J Merkord; H Weber; G Kröning; G Hennighausen
Journal:  Hum Exp Toxicol       Date:  2001-08       Impact factor: 2.903

5.  Etiology, pathology, management and prognosis of chronic pancreatitis in Chinese population: A retrospective study.

Authors:  Soriba Naby Camara; Sonam Ramdany; Gang Zhao; Shan-Miao Gou; Jiong-Xin Xiong; Zhi-Yong Yang; Tao Yin; Ming Yang; Oumar Taibata Balde; Ahmed Boubacar Barry; Seid Adji; Xiang Li; Yan Jin; He-Shui Wu; Chun-You Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

6.  A mouse model of ethanol dependent pancreatic fibrosis.

Authors:  G Perides; X Tao; N West; A Sharma; M L Steer
Journal:  Gut       Date:  2005-05-03       Impact factor: 23.059

Review 7.  Chronic pancreatitis.

Authors:  Joan M Braganza; Stephen H Lee; Rory F McCloy; Michael J McMahon
Journal:  Lancet       Date:  2011-04-02       Impact factor: 79.321

8.  Pancreatitis-associated protein inhibits human pancreatic stellate cell MMP-1 and -2, TIMP-1 and -2 secretion and RECK expression.

Authors:  Ling Li; Max G Bachem; Shaoxia Zhou; Zilin Sun; Jinfei Chen; Marco Siech; Daniel Bimmler; Rolf Graf
Journal:  Pancreatology       Date:  2008-12-12       Impact factor: 3.996

9.  Transforming growth factor-α activates pancreatic stellate cells and may be involved in matrix metalloproteinase-1 upregulation.

Authors:  Hiroki Tahara; Ken Sato; Yuichi Yamazaki; Tatsuya Ohyama; Norio Horiguchi; Hiroaki Hashizume; Satoru Kakizaki; Hitoshi Takagi; Iwata Ozaki; Hideo Arai; Junko Hirato; Ralf Jesenofsky; Atsushi Masamune; Masatomo Mori
Journal:  Lab Invest       Date:  2013-04-22       Impact factor: 5.662

10.  Influence of matrix metalloproteinase-1 gene -1607 (1G/2G) (rs1799750) promoter polymorphism on circulating levels of MMP-1 in chronic pancreatitis.

Authors:  K Sri Manjari; Pratibha Nallari; N Balakrishna; A Vidyasagar; B Prabhakar; A Jyothy; A Venkateshwari
Journal:  Biochem Genet       Date:  2013-05-05       Impact factor: 1.890

View more
  7 in total

Review 1.  Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Zobeida Cruz-Monserrate; Brian M Davis; Mouad Edderkaoui; Guido Eibl; Ariel Y Epouhe; Jeremy Y Gedeon; Fred S Gorelick; Paul J Grippo; Guy E Groblewski; Sohail Z Husain; Keane K Y Lai; Stephen J Pandol; Aliye Uc; Li Wen; David C Whitcomb
Journal:  Pancreas       Date:  2019-07       Impact factor: 3.327

2.  Methods of a New Chronic Pancreatitis and Spontaneous Pancreatic Cancer Mouse Model Using Retrograde Pancreatic Duct Injection of Dibutyltin Dichloride.

Authors:  Deyu Zhang; Wanshun Li; Meiqi Wang; Hua Yin; Chuanchao Xia; Keliang Li; Haojie Huang
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

3.  COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS.

Authors:  Zheying Zhang; Cheng Fang; Yongxia Wang; Jinghang Zhang; Jian Yu; Yongxi Zhang; Xianwei Wang; Jiateng Zhong
Journal:  Int J Oncol       Date:  2018-08-22       Impact factor: 5.650

4.  Effects of Perinatal Exposure to Dibutyltin Chloride on Fat and Glucose Metabolism in Mice, and Molecular Mechanisms, in Vitro.

Authors:  Raquel Chamorro-García; Bassem M Shoucri; Sigal Willner; Heidi Käch; Amanda Janesick; Bruce Blumberg
Journal:  Environ Health Perspect       Date:  2018-05-21       Impact factor: 9.031

Review 5.  Mesenchymal stem cells in fibrotic diseases-the two sides of the same coin.

Authors:  Lei Qin; Nian Liu; Chao-le-Meng Bao; Da-Zhi Yang; Gui-Xing Ma; Wei-Hong Yi; Guo-Zhi Xiao; Hui-Ling Cao
Journal:  Acta Pharmacol Sin       Date:  2022-07-27       Impact factor: 7.169

6.  Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.

Authors:  Olga Prokopchuk; Barbara Grünwald; Ulrich Nitsche; Carsten Jäger; Oleksii L Prokopchuk; Elaine C Schubert; Helmut Friess; Marc E Martignoni; Achim Krüger
Journal:  BMC Cancer       Date:  2018-02-02       Impact factor: 4.430

7.  COL1A1 promotes metastasis in colorectal cancer by regulating the WNT/PCP pathway.

Authors:  Zheying Zhang; Yongxia Wang; Jinghang Zhang; Jiateng Zhong; Rui Yang
Journal:  Mol Med Rep       Date:  2018-02-01       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.